Mark B. Benjamin
Präsident bei Cyrus Biotechnology, Inc.
Profil
Mark B.
Benjamin is currently the President & Executive VP-Business Development at Cyrus Biotechnology, Inc. Previously, he worked as a Senior Business Development Executive at Rosetta Inpharmatics LLC from 1999 to 2001.
He also served as the Chief Business Officer at Nura, Inc. Additionally, he was a Trustee at Seattle Biomedical Research Institute.
Dr. Benjamin holds a doctorate degree from Harvard University and an undergraduate degree from the University of London.
Aktive Positionen von Mark B. Benjamin
| Unternehmen | Position | Beginn |
|---|---|---|
Cyrus Biotechnology, Inc.
 Cyrus Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Cyrus Biotechnology, Inc. develops protein structure prediction and protein design software. The company was founded by Lucas Nivon, David Baker, Javier Castellanos and Yifan Song and is headquartered in Seattle, WA | Präsident | - |
Ehemalige bekannte Positionen von Mark B. Benjamin
| Unternehmen | Position | Ende |
|---|---|---|
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Corporate Officer/Principal | 01.01.2001 |
Seattle Biomedical Research Institute
 Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
Nura, Inc.
 Nura, Inc. Pharmaceuticals: MajorHealth Technology Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Ausbildung von Mark B. Benjamin
| Harvard University | Doctorate Degree |
| University of London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
Nura, Inc.
Nura, Inc. Pharmaceuticals: MajorHealth Technology Nura, Inc. discovers and develops pharmaceutical products. It offers products for the treatment of neurodegenerative diseases such as Parkinson's & Alzheimer's diseases and behavioural disorders such as depression, anxiety, schizophrenia, obesity, and addiction. The company was founded in August 2003 and is headquartered in Seattle, WA. | Health Technology |
Seattle Biomedical Research Institute
Seattle Biomedical Research Institute Miscellaneous Commercial ServicesCommercial Services Seattle Biomedical Research Institute operates as a non-profit organization that researches and discovers infectious diseases. It provides research for new drugs, vaccines, and diagnostics. The company was founded by Kenneth D. Stuart and Ruth W. Shearer in 1976 and is headquartered in Seattle, WA. | Commercial Services |
Cyrus Biotechnology, Inc.
Cyrus Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Cyrus Biotechnology, Inc. develops protein structure prediction and protein design software. The company was founded by Lucas Nivon, David Baker, Javier Castellanos and Yifan Song and is headquartered in Seattle, WA | Commercial Services |
